OpenURL Connection Search

Select item for more details and to access through your institution.

Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 12, p. 1578, doi. 10.1111/apt.14672
By:
- Ma, C.;
- Guizzetti, L.;
- Panaccione, R.;
- Fedorak, R. N.;
- Pai, R. K.;
- Parker, C. E.;
- Nguyen, T. M.;
- Khanna, R.;
- Vande Casteele, N.;
- D'Haens, G.;
- Sandborn, W. J.;
- Feagan, B. G.;
- Jairath, V.
Publication type:
Article
High body mass index is associated with increased risk of treatment failure and surgery in biologic‐treated patients with ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 11, p. 1472, doi. 10.1111/apt.14665
By:
- Kurnool, S.;
- Nguyen, N. H.;
- Proudfoot, J.;
- Dulai, P. S.;
- Boland, B. S.;
- Vande Casteele, N.;
- Evans, E.;
- Grunvald, E. L.;
- Zarrinpar, A.;
- Sandborn, W. J.;
- Singh, S.
Publication type:
Article
Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 229, doi. 10.1111/apt.14421
By:
- Vande Casteele, N.;
- Feagan, B. G.;
- Vermeire, S.;
- Yassine, M.;
- Coarse, J.;
- Kosutic, G.;
- Sandborn, W. J.
Publication type:
Article
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1037, doi. 10.1111/apt.14368
By:
- Mitrev, N.;
- Vande Casteele, N.;
- Seow, C. H.;
- Andrews, J. M.;
- Connor, S. J.;
- Moore, G. T.;
- Barclay, M.;
- Begun, J.;
- Bryant, R.;
- Chan, W.;
- Corte, C.;
- Ghaly, S.;
- Lemberg, D. A.;
- Kariyawasam, V.;
- Lewindon, P.;
- Martin, J.;
- Mountifield, R.;
- Radford‐Smith, G.;
- Slobodian, P.;
- Sparrow, M.
Publication type:
Article
Editorial: variability in adalimumab trough and peak serum concentrations.
Published in:
2017
By:
- Vande Casteele, N.;
- Gils, A.
Publication type:
Editorial
The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 10, p. 1329, doi. 10.1111/apt.14040
By:
- Seow, C. H.;
- Leung, Y.;
- Vande Casteele, N.;
- Ehteshami Afshar, E.;
- Tanyingoh, D.;
- Bindra, G.;
- Stewart, M. J.;
- Beck, P. L.;
- Kaplan, G. G.;
- Ghosh, S.;
- Panaccione, R.
Publication type:
Article
Review article: dose optimisation of infliximab for acute severe ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 5, p. 617, doi. 10.1111/apt.13913
By:
- Hindryckx, P.;
- Novak, G.;
- Vande Casteele, N.;
- Laukens, D.;
- Parker, C.;
- Shackelton, L. M;
- Narula, N.;
- Khanna, R.;
- Dulai, P.;
- Levesque, B. G;
- Sandborn, W. J;
- D'Haens, G.;
- Feagan, B. G.;
- Jairath, V.
Publication type:
Article
Review article: pharmacological aspects of anti- TNF biosimilars in inflammatory bowel diseases.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 10, p. 1158, doi. 10.1111/apt.13402
By:
- Papamichael, K.;
- Van Stappen, T.;
- Jairath, V.;
- Gecse, K.;
- Khanna, R.;
- D'Haens, G.;
- Vermeire, S.;
- Gils, A.;
- Feagan, B. G.;
- Levesque, B. G.;
- Vande Casteele, N.
Publication type:
Article
Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 11/12, p. 1324, doi. 10.1111/apt.12968
By:
- Baert, F.;
- Vande Casteele, N.;
- Tops, S.;
- Noman, M.;
- Van Assche, G.;
- Rutgeerts, P.;
- Gils, A.;
- Vermeire, S.;
- Ferrante, M.
Publication type:
Article
Letter: dry blood spots for anti-TNF treatment monitoring in IBD.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 10, p. 1024, doi. 10.1111/apt.12283
By:
- Vande Casteele, N.;
- Brecx, S.;
- Declerck, P.;
- Ferrante, M.;
- Rutgeerts, P.;
- Vermeire, S.;
- Gils, A.
Publication type:
Article
Letter: detection of infliximab levels and anti-infliximab antibodies - comparison of three different assays; authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 2, p. 282, doi. 10.1111/apt.12128
By:
- Buurman, D. J.;
- Vande Casteele, N.;
- Sturkenboom, M. G. G.;
- Kleibeuker, J. H.;
- Vermeire, S.;
- Kleij, D.;
- Rispens, T.;
- Gils, A.;
- Dijkstra, G.
Publication type:
Article
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 8, p. 765, doi. 10.1111/apt.12030
By:
- Vande Casteele, N.;
- Buurman, D. J.;
- Sturkenboom, M. G. G.;
- Kleibeuker, J. H.;
- Vermeire, S.;
- Rispens, T.;
- Kleij, D.;
- Gils, A.;
- Dijkstra, G.
Publication type:
Article
Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 3, p. 401, doi. 10.1111/j.1365-2036.2011.04726.x
By:
- Vande Casteele, N.;
- Breynaert, C.;
- Vermeire, S.;
- Rutgeerts, P. J.;
- Gils, A.;
- Van Assche, G.
Publication type:
Article

Found: 13